Dilantin and Sotalol hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin and Sotalol hydrochloride. Common interactions include anaemia among females and cardiogenic shock among males.

The phase IV clinical study analyzes what interactions people who take Dilantin and Sotalol hydrochloride have. It is created by eHealthMe based on reports of 7 people who take Dilantin and Sotalol hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 07, 2022

7 people who take Dilantin and Sotalol hydrochloride together, and have interactions are studied.


What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,831 Dilantin users for its effectiveness, alternative drugs and more.

What is Sotalol hydrochloride?

Sotalol hydrochloride has active ingredients of sotalol hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,127 Sotalol hydrochloride users for its effectiveness, alternative drugs and more.

Number of Dilantin and Sotalol hydrochloride reports submitted per year:

Dilantin and Sotalol hydrochloride drug interactions.

Common Dilantin and Sotalol Hydrochloride drug interactions by gender *:

female:

  1. Anaemia
  2. Anoxia
  3. Anxiety
  4. Asthenia
  5. Autoimmune disorder
  6. Blood pressure decreased
  7. Bundle branch block right
  8. Cardiac failure congestive
  9. Cardiomegaly
  10. Coma

male:

  1. Cardiogenic shock
  2. Cerebrovascular accident
  3. Hypotension
  4. Infection
  5. Injection site cellulitis
  6. Thrombophlebitis

Common Dilantin and Sotalol Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anoxia
  2. Blood pressure decreased
  3. Cardiac arrest
  4. Coma
  5. Convulsions
  6. Nausea
  7. Nodal arrhythmia
  8. Supraventricular tachycardia
  9. Vomiting

60+:

  1. Abdominal distension
  2. Anaemia
  3. Contusion
  4. Convulsion
  5. Decreased appetite
  6. Delusion
  7. Dilatation ventricular
  8. Dizziness postural
  9. Dry skin
  10. Electrocardiogram qt prolonged

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Sotalol hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Dilantin and Sotalol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dilantin interactions:

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sotalol hydrochloride interactions:

Browse all interactions between Sotalol hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and sotalol hydrochloride (the active ingredients of Dilantin and Sotalol hydrochloride, respectively), and Dilantin and Sotalol hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: